Home » Topics » BioWorld Science

BioWorld Science
RSS

KURBF discloses new CRLF2 ligands as IL-6 production inhibitors

Aug. 3, 2018

Jiangsu Tasly Diyi Pharmaceutical describes SGLT2 inhibitors

Aug. 3, 2018

Ardelyx patents new NHE-3 inhibitors

Aug. 3, 2018

Spring Bank Pharmaceuticals reports results from third cohort of ACHIEVE study of inarigivir

Aug. 3, 2018

Aptinyx begins first-in-human study of NYX-458

Aug. 3, 2018

Celtaxsys reports topline results from phase II EMPIRE-CF trial

Aug. 3, 2018

TiumBio presents preclinical data for NBP-604, a new fusion protein for hemophilia

Aug. 3, 2018

Asahi Kasei presents preliminary results of SCARLET phase III trial of ART-123

Aug. 3, 2018

Researchers develop new rat model of tauopathy with severe cognitive deficits

Aug. 3, 2018

Emergent BioSolutions starts phase I study of ZIKV-IG

Aug. 3, 2018

Popular Stories

Today's news in brief
BioWorld
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...